Community Acquired Bacteremic Syndromes in Young Nigerian Children
NCT02946775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29146
Last updated 2023-09-29
Summary
To define the etiologic agents of community acquired bacteremic syndromes (defined as septicemia, bacteremia, pneumonia and/or meningitis) in a malaria endemic setting.
Conditions
- Community-Acquired Infections
Sponsors & Collaborators
-
University of Nebraska
lead OTHER
Principal Investigators
-
Stephen K Obaro, MD · University of Nebraska
Eligibility
- Min Age
- 1 Minute
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-13
- Primary Completion
- 2018-07-01
- Completion
- 2018-07-01
Countries
- Nigeria
Study Locations
More Related Trials
-
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931 ·Status: COMPLETED
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso
NCT00463528 ·Status: COMPLETED
-
Pathogenesis and Management of M. Ulcerans Disease, Buruli Ulcer
NCT02153034 ·Status: UNKNOWN
-
Circulating Cathodic Antigen Test Compared to Microscopy for Diagnosis of Urinary Schistosomiasis in Sohag
NCT05276414 ·Status: UNKNOWN
-
Rheumatic Heart Disease Study in Lusaka
NCT02661763 ·Status: COMPLETED
-
Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
NCT00463593 ·Status: COMPLETED
-
Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
NCT02878564 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Intestinal Parasitic Infections in Under-Five Children With Malnutrition in Sohag, Egypt
NCT06716060 ·Status: RECRUITING
-
Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment
NCT02495909 ·Status: COMPLETED
-
Parasitological Evaluation of Fascioliasis in Clinically Suspected Patients .
NCT03869788 ·Status: UNKNOWN
-
Assessment of Burden Disease in Patients With Mast Cell Disorders
NCT04615663 ·Status: UNKNOWN
-
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
NCT04301752 ·Status: COMPLETED
-
Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India
NCT01629771 ·Status: COMPLETED
-
Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya
NCT00463307 ·Status: COMPLETED
-
Lymphatic Filariasis (LF) in Ivory Coast
NCT02974049 ·Status: COMPLETED ·Phase: NA
-
Effect of Albendazole Dose on Clearance of Filarial Worms
NCT00339417 ·Status: COMPLETED ·Phase: PHASE2
-
Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
NCT00463632 ·Status: COMPLETED
-
Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal
NCT01553552 ·Status: COMPLETED
-
Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06335160 ·Status: RECRUITING ·Phase: NA
-
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
NCT02734186 ·Status: WITHDRAWN ·Phase: PHASE4
-
Urinary Schistosomiasis Infection
NCT00138450 ·Status: COMPLETED
-
Schistosoma Haematobium Infections and Praziquantel
NCT01558336 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Drug Combinations Against Schistosomiasis
NCT01050374 ·Status: COMPLETED ·Phase: NA
-
Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment
NCT00414479 ·Status: COMPLETED